A comprehensive industry overview and market perspective are included in the latest study from MarkNtel Advisors titled Global Immuno-Oncology Assay Market. The research provides a detailed overview of the current market state, including market trends and the most recent advancements made globally. In-depth analysis of market size, share, industry trends, forecast, and competitive environment is covered in the report that presents clear picture of the market with relevant statistical data.
The report combines in-depth quantitative analysis with qualitative analysis; it ranges from macro-overviews of the overall market size, industry chain, and market dynamics to micro details of segment markets. This, as a result, provides a thorough overview of the industry under study as well as a profound understanding of all of its important features.
Global Immuno-Oncology Assay Market Definition:
The Global Immuno-Oncology Assay Market involves the development and distribution of diagnostic tools for detecting and characterizing cancers within the field of Immuno-Oncology. The market focuses on biomarker assays, genetic profiling, and immune system assessments to enable early cancer diagnosis, prognosis, and personalized treatment selection.
Request Sample Report- https://www.marknteladvisors.com/query/request-sample/immuno-oncology-assay-market.html
Global Immuno-Oncology Assay Market Insights:
The Global Immuno-Oncology Assay Market size is estimated to grow at a CAGR of around 12.5% during the forecast period, i.e., 2023-28.
Global Immuno-Oncology Assay Market Driver:
Increasing Cancer Cases Globally to Drive Immuno-Oncology Assay Market- The substantial growth in the Global Immuno-Oncology Assay Market has been attributed to the increasing prevalence of cancer globally. The global incidence of cancer has risen significantly, with notable increases reported in countries such as the US and India, as documented by leading healthcare organizations like the World Health Organization, the International Agency for Research on Cancer, and the Global Cancer Observatory. For instance,
- In 2018, the Global Cancer Observatory recorded approximately 18.1 million cancer cases worldwide, a number that escalated to approximately 19.2 million by 2020.
This surge in cancer cases has underscored the imperative for effective management. Consequently, countries, particularly the United States and India, have implemented measures to combat cancer, leading to heightened awareness among patients. This heightened awareness has driven the need for immune-oncology assays globally, catering to the need for early-stage detection and diagnosis.
Furthermore, global cancer research and healthcare organizations predict a continued increase in cancer cases in the years ahead. This prediction is based on factors such as the proliferation of carcinogenic pollutants in the environment and the growing prevalence of genetic mutations as significant contributors to cancer development. As a result, the demand for better immune-oncology diagnostic services would amplify in the coming years as well.
Global Immuno-Oncology Assay Market Leading Key Players:
Agilent Technologies Inc., Aviva Systems Biology Corporation, PerkinElmer Inc., Bio-Rad Laboratories, Inc., Illumina Inc., Qiagen N.V, Thermo Fisher Scientific, Inc., Sartorius AG, NanoString Technologies, Inc., BioGenex, Abbott Laboratories, Inc., Asuragen Inc., Meso Scale Assay, LLC, Merck Millipore, Enzo Biochem Inc., and Others
Browse Full Report - https://www.marknteladvisors.com/research-library/immuno-oncology-assay-market.html
Global Immuno-Oncology Assay Market Segmentation:
Based on Product Services
- Reagents and Antibodies- Market Size Forecast 2018-2028F, USD Million
- Testing Kits- Market Size Forecast 2018-2028F, USD Million
- Instruments- Market Size Forecast 2018-2028F, USD Million
- Consumables Accessories- Market Size Forecast 2018-2028F, USD Million
- Software- Market Size Forecast 2018-2028F, USD Million
Based on Assay Type
- Checkpoint Inhibitor Assays- Market Size Forecast 2018-2028F, USD Million
- Cytokine Profiling Assays- Market Size Forecast 2018-2028F, USD Million
- Protein Biomarker Assays- Market Size Forecast 2018-2028F, USD Million
- Genomic Sequencing and Mutational Analysis- Market Size Forecast 2018-2028F, USD Million
- Immune Profiling Assays- Market Size Forecast 2018-2028F, USD Million
- Tumour Biomarker Assays- Market Size Forecast 2018-2028F, USD Million
- Others (Gene Expression Profiling Assays, Multiplex Assays, etc.)- Market Size Forecast 2018-2028F, USD Million
Based on Technology
- Polymerase Chain Reaction- Market Size Forecast 2018-2028F, USD Million
- Immunoassay- Market Size Forecast 2018-2028F, USD Million
- Next-generation Sequencing- Market Size Forecast 2018-2028F, USD Million
- In-situ Hybridization- Market Size Forecast 2018-2028F, USD Million
- Flow Cytometry- Market Size Forecast 2018-2028F, USD Million
- Others (Mass Spectrometry, Immunohistochemistry (IHC), etc.) - Market Size Forecast 2018-2028F, USD Million
Based on Indication
- Lung Cancer- Market Size Forecast 2018-2028F, USD Million
- Breast Cancer- Market Size Forecast 2018-2028F, USD Million
- Colorectal Cancer- Market Size Forecast 2018-2028F, USD Million
- Prostate Cancer- Market Size Forecast 2018-2028F, USD Million
- Ovarian Cancer- Market Size Forecast 2018-2028F, USD Million
- Others (Bladder Cancer, Melanoma, etc.)- Market Size Forecast 2018-2028F, USD Million
Based on Application
- Clinical Assay- Market Size Forecast 2018-2028F, USD Million
- Research Development- Market Size Forecast 2018-2028F, USD Million
Based on End User
- Hospitals- Market Size Forecast 2018-2028F, USD Million
- Cancer Research Centers- Market Size Forecast 2018-2028F, USD Million
- Specialty Cancer Clinics- Market Size Forecast 2018-2028F, USD Million
- Clinical Laboratories- Market Size Forecast 2018-2028F, USD Million
- Others (Contract Research Organizations (CROs), Contract Development Manufacturing Organizations (CDMOs), etc.) - Market Size Forecast 2018-2028F, USD Million
Talk to our Consultant - https://www.marknteladvisors.com/query/talk-to-our-consultant/immuno-oncology-assay-market.html
Global Immuno-Oncology Assay Market Geographical Analysis
By Region
- North America
- South America
- Europe
- Middle East Africa
- Asia-Pacific
Recent Development of Global Immuno-Oncology Assay Market:
2023: Bio-Rad Laboratories, Inc. and Cytek Biosciences collaborated to utilize Bio-Rad's StarBright™ Dyes for creating reagent products that enhance high-parameter applications on Cytek's Aurora and Northern Lights™ flow cytometry systems, boosting their immuno-oncology assay and immunotherapy research capabilities.
Request Customization - https://www.marknteladvisors.com/query/request-customization/immuno-oncology-assay-market.html
About Us:
MarkNtel Advisors is a leading research, consulting, data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial varied client base, including multinational corporations, financial institutions, governments, individuals, among others.
Our specialization in niche industries emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing forecasting, trend analysis, among others, for 15 diverse industrial verticals.
Contact us:
If you have any questions, our team of trained and professional experts is here to help. You can get in touch with us by calling, sending an email, or using our online contact form.
We will try our best to answer your request as quickly as we can and give you the details you require.
Call: ? +1 628 895 8081, +91 120 4278433
Email: ? [email protected]
Visit to know more: ? https://www.marknteladvisors.com/
